Form 8-K - Current report:
SEC Accession No. 0001213900-25-053603
Filing Date
2025-06-12
Accepted
2025-06-12 08:30:12
Documents
13
Period of Report
2025-06-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0245415-8k_synergy.htm   iXBRL 8-K 26274
2 FORM OF PRE-FUNDED WARRANT ea024541501ex4-1_synergy.htm EX-4.1 87260
  Complete submission text file 0001213900-25-053603.txt   298841

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snyr-20250611.xsd EX-101.SCH 3020
4 XBRL LABEL FILE snyr-20250611_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE snyr-20250611_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0245415-8k_synergy_htm.xml XML 3558
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42374 | Film No.: 251041731
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)